Here, authors provide their perspective on the potential of engineering biology for environmental biotechnology, summarizing their thoughts on the key challenges and future possibilities for the ...

Or, maybe, it's just a grey wolf with a few tweaks. American biotech company Colossal Biosciences made a surprise announcement Monday, claiming it had brought the dire wolf back from the dead ...

America must invest at least $15 billion over the next five years to support its domestic biotechnology sector if it doesn’t want to lose to China, warns a national security commission made up ...

However, the prospect of future industry-specific tariffs could intensify selling pressure on biotech stocks. Despite the uncertainty, top hedge fund managers have invested millions of dollars in ...

The U.S.-based biotechnology company is also known for its ambitious goal of bringing back the extinct woolly mammoth by 2028. This dire wolf pup is among the first of its species born in around ...

The National Security Commission on Emerging Biotechnology recommends at least a $15 billion investment into biotech over the next five years. A congressional commission is sounding the alarm on the ...

Caitlin O'Kane is a New York City journalist who works on the CBS News social media team as a senior manager of content and production. She writes about a variety of topics and produces "The ...

A biotech company says it has bred three animals with key physical features of the dire wolf — a species that has been extinct for more than 12,000 years. Colossal Biosciences says it used novel ...

Legend Biotech has no tariff exposure and manufactures Carvykti entirely in the U.S. for both U.S. and EU markets. HC Wainwright maintains a $75 target, citing Carvykti’s strong efficacy and ...